Akoma is an iPhone app that helps adults on GLP-1 medications track their journey calmly and privately. It logs injections, weight, side effects, meals and water in one place, with rotation reminders, honest weight trends and shot streaks. Akoma is published by a UK-based team and is available worldwide on the App Store.

Is Akoma available now?

Yes. Akoma is live on the Apple App Store as of 2026. It is available worldwide in every country where the App Store operates.

Which medications does Akoma support?

Akoma supports all common GLP-1 and GIP/GLP-1 medications, including Mounjaro (tirzepatide), Wegovy (semaglutide), Ozempic (semaglutide), Saxenda (liraglutide) and Victoza (liraglutide). Custom medications and doses can also be configured.

What can Akoma track?

Akoma tracks injection dose, site and timing with rotation reminders; weight; side effects; meals (with optional photo-based macro estimation); water intake; and daily and weekly progress. Apple Health integration reads weight, water and steps, and writes water back to Health.

Where can I download Akoma?

Akoma can be downloaded from the Apple App Store on any iPhone running iOS 17 or later. The direct App Store link is https://apps.apple.com/app/akoma-glp-1-companion/id6762615713.

Is Akoma a UK-only app?

No. Akoma is published by a UK-based team but is available worldwide on the Apple App Store. There is no regional restriction; users in the United States, Canada, Australia, New Zealand, Europe, Asia and the rest of the world can all download and use Akoma.

How much does Akoma cost?

Akoma is free to download and requires Akoma Premium to unlock the main tracking experience after onboarding. Akoma Premium is an auto-renewing subscription billed by Apple. Eligible new annual subscribers can start with a 3-day free trial, and subscriptions can be cancelled at any time in iPhone Settings.

Yes. Akoma is privacy-first by design. Your core logs are handled as health data and stored securely. Akoma does not sell your data, does not show ads, does not request IDFA access, and does not use your meal photos to train AI models. Privacy-safe app events may be sent to Meta and TikTok without medication names, weight values, symptoms, meals, notes, photos, email addresses, names, or user identifiers. The full privacy policy is published at https://akomahealthcare.com/legal/privacy.

Does Akoma require a web account?

No. Akoma is a native iOS app and does not require a web login. Users sign in inside the app with Sign in with Apple or Sign in with Google.

Is Akoma a medical device or a replacement for medical advice?

No. Akoma is a wellness and tracking companion. It is not a medical device and does not provide medical advice, diagnosis or treatment. Users should always follow the guidance of their prescribing clinician.

How is Akoma different from other GLP-1 apps like Shotsy, MeAgain, Glapp or ShotTrack?

Akoma is purpose-built around the GLP-1 medication journey rather than aggressive weight-loss gamification. It combines injection tracking with rotation reminders, side-effect logging, low-effort meal logging (snap a photo, no calorie counting required), and quiet weight trends in one calm interface. Akoma is privacy-first, native iOS, requires no web account, and is available worldwide on the Apple App Store today.

Akoma is made by a UK-based independent team focused on building calm, privacy-respecting health tools. Support and press enquiries can be sent to hello@akomahealthcare.com.

Akoma vs Shotsy: choosing a GLP-1 tracker

Akoma and Shotsy fit different GLP-1 routines. Here is how a full-week tracker compares with a lighter injection-first app on iPhone.

By the Akoma team6 July 20267 min read

Akoma and Shotsy solve related but different jobs. If you are comparing them, the real question is not which app wins on paper. It is whether you want a lighter injection-first log or a fuller GLP-1 tracker that keeps the whole week together.

That difference matters because most adults on GLP-1 medications are not only trying to remember the shot. They are often also trying to notice side-effect timing, appetite shifts, meals that felt manageable, hydration, weight trends and what changed between one dose week and the next.

Where Shotsy may fit better

Shotsy may fit better if your main priority is a lighter injection log. Some people want the medication date, dose and a simple history view, then prefer to handle meals, weight or symptoms somewhere else. If that is your routine, a narrower app can feel cleaner.

This can also suit people who already have another system they like for food, hydration or progress and do not want to merge everything into a single GLP-1 tracker app.

Where Akoma may fit better

Akoma is built for a broader weekly routine. It brings injections, injection-site rotation, side effects, meals, water, weight and weekly reflection into one calm iPhone app. That is useful when the pattern around the shot matters as much as the shot itself.

A fuller view can make follow-up appointments easier too. Instead of trying to reconstruct the week from memory, you can review whether nausea showed up after dose day, whether lower appetite affected meals, and whether hydration or weight trends shifted at the same time.

Akoma vs Shotsy on the questions that usually matter

1. Injection logging

Both categories can cover the basics of logging the shot. The decision is whether that basic log is enough for you or whether you want that entry connected to the rest of your week.

2. Injection-site rotation

If you want site rotation to stay visible over time, Akoma is designed around that habit. For people on Mounjaro, Wegovy, Ozempic or similar medications, remembering the exact area used last week gets harder over months, not easier.

3. Side effects, meals and water

This is where the split becomes clearer. A lighter injection app may be enough if you do not want to track anything else. Akoma fits better if you want nausea, appetite changes, meals and hydration in the same place as dose timing, because those signals often explain each other.

4. Weight and weekly patterns

Some users want a broader weekly review, not just a record of the shot. If that is you, a full GLP-1 tracker can be more useful than a narrow injection log because it shows the routine behind the trend rather than one isolated event.

Which kind of GLP-1 user each app fits

Choose a lighter injection-first app if you mainly want a simple shot record and you are happy using other tools for everything else.

Choose Akoma if you want one calmer place for injections, side effects, meals, water and weight, without turning the experience into a generic fitness workflow.

Where Akoma fits

Akoma is a native iPhone companion for adults on GLP-1 medications. It is designed for people who want the weekly routine in one place rather than a single-purpose log. It is not a medical device and does not replace clinician guidance.

Akoma is free to download on the Apple App Store. Akoma Premium unlocks the main tracking experience after onboarding; eligible new annual subscribers can start with a 3-day free trial.

Privacy claims stay straightforward: no ads, no IDFA request, no selling health data, and no health logs sent to ad networks.

Quick FAQ

What is the main difference between Akoma and Shotsy?

Shotsy is a lighter injection-first tracker. Akoma is built for adults on GLP-1 medications who want injections, side effects, meals, water, weight and weekly reflection in one iPhone app.

Which app fits better for a full GLP-1 routine?

Choose a lighter injection-first tracker if you mainly want to log shots and review that history. Choose a fuller GLP-1 tracker if you want injections, symptoms, meal patterns, hydration and progress together.

Can Akoma replace a separate injection log app?

For many iPhone users, yes. Akoma includes dose logging, injection-site tracking, reminders, side effects, meals, water, weight and weekly notes in one place.

The calm GLP-1 companion for iPhone.

Akoma tracks injections (with rotation reminders), weight, side effects, meals and water in one private place. Worldwide on the App Store.

Available on the

App Store